 | • レポートコード：D0GIR-00211 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、組換え治療用抗体・タンパク質の世界市場を広く調査・分析し、今後の市場展望をまとめております。組換え治療用抗体・タンパク質の種類別市場規模（血漿タンパク質、融合タンパク質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他）、用途別市場規模（腫瘍学、血液学、免疫学、内分泌学、感染症、心血管疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Novo Nordisk、Eli Lilly、Amgen、Merck、Biogen、Sanofi、Johnson and Johnson、Roche、Pfizer ・地域別グローバル市場分析 2015年-2020年 ・組換え治療用抗体・タンパク質の北米市場（アメリカ、カナダ、メキシコ） ・組換え治療用抗体・タンパク質のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・組換え治療用抗体・タンパク質のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・組換え治療用抗体・タンパク質の南米市場（ブラジル、アルゼンチン） ・組換え治療用抗体・タンパク質の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：血漿タンパク質、融合タンパク質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他 ・用途別分析：腫瘍学、血液学、免疫学、内分泌学、感染症、心血管疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Recombinant Therapeutic Antibodies and Proteins market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 118990 million by 2025, from USD 92080 million in 2019.
The Recombinant Therapeutic Antibodies and Proteins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Recombinant Therapeutic Antibodies and Proteins market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Recombinant Therapeutic Antibodies and Proteins market has been segmented into:
Plasma Protein
Fusion Proteins
Monoclonal Antibodies
Hormones
Enzyme
Coagulation Factors
Others
By Application, Recombinant Therapeutic Antibodies and Proteins has been segmented into:
Oncology
Hematology
Immunology
Endocrinology
Infectious Disease
Cardiovascular Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant Therapeutic Antibodies and Proteins market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant Therapeutic Antibodies and Proteins markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant Therapeutic Antibodies and Proteins market.
The report offers in-depth assessment of the growth and other aspects of the Recombinant Therapeutic Antibodies and Proteins market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Recombinant Therapeutic Antibodies and Proteins Market Share Analysis
Recombinant Therapeutic Antibodies and Proteins competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant Therapeutic Antibodies and Proteins sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant Therapeutic Antibodies and Proteins sales, revenue and market share for each player covered in this report.
The major players covered in Recombinant Therapeutic Antibodies and Proteins are:
Abbott
Novo Nordisk
Eli Lilly
Amgen
Merck
Biogen
Sanofi
Johnson and Johnson
Roche
Pfizer
Table of Contents
1 Recombinant Therapeutic Antibodies and Proteins Market Overview
1.1 Product Overview and Scope of Recombinant Therapeutic Antibodies and Proteins
1.2 Classification of Recombinant Therapeutic Antibodies and Proteins by Type
1.2.1 Global Recombinant Therapeutic Antibodies and Proteins Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Type in 2019
1.2.3 Plasma Protein
1.2.4 Fusion Proteins
1.2.5 Monoclonal Antibodies
1.2.6 Hormones
1.2.7 Enzyme
1.2.8 Coagulation Factors
1.2.9 Others
1.3 Global Recombinant Therapeutic Antibodies and Proteins Market by Application
1.3.1 Overview: Global Recombinant Therapeutic Antibodies and Proteins Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Hematology
1.3.4 Immunology
1.3.5 Endocrinology
1.3.6 Infectious Disease
1.3.7 Cardiovascular Disease
1.3.8 Others
1.4 Global Recombinant Therapeutic Antibodies and Proteins Market by Regions
1.4.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Recombinant Therapeutic Antibodies and Proteins (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Recombinant Therapeutic Antibodies and Proteins Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novo Nordisk SWOT Analysis
2.2.4 Novo Nordisk Product and Services
2.2.5 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biogen
2.6.1 Biogen Details
2.6.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biogen SWOT Analysis
2.6.4 Biogen Product and Services
2.6.5 Biogen Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sanofi SWOT Analysis
2.7.4 Sanofi Product and Services
2.7.5 Sanofi Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson and Johnson
2.8.1 Johnson and Johnson Details
2.8.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson and Johnson SWOT Analysis
2.8.4 Johnson and Johnson Product and Services
2.8.5 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer SWOT Analysis
2.10.4 Pfizer Product and Services
2.10.5 Pfizer Recombinant Therapeutic Antibodies and Proteins Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Recombinant Therapeutic Antibodies and Proteins Players Market Share
3.2.2 Top 10 Recombinant Therapeutic Antibodies and Proteins Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Regions
4.2 North America Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
4.3 Europe Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
4.5 South America Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
5 North America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries
5.1 North America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2015-2020)
5.2 USA Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
5.3 Canada Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
5.4 Mexico Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
6 Europe Recombinant Therapeutic Antibodies and Proteins Revenue by Countries
6.1 Europe Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2015-2020)
6.2 Germany Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
6.3 UK Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
6.4 France Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
6.5 Russia Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
6.6 Italy Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue by Countries
7.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2015-2020)
7.2 China Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
7.3 Japan Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
7.4 Korea Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
7.5 India Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
8 South America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries
8.1 South America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2015-2020)
8.2 Brazil Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
8.3 Argentina Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Recombinant Therapeutic Antibodies and Proteins by Countries
9.1 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2015-2020)
9.2 Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
9.3 UAE Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
9.4 Egypt Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
9.5 South Africa Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Recombinant Therapeutic Antibodies and Proteins Revenue and Market Share by Type (2015-2020)
10.2 Global Recombinant Therapeutic Antibodies and Proteins Market Forecast by Type (2019-2024)
10.3 Plasma Protein Revenue Growth Rate (2015-2025)
10.4 Fusion Proteins Revenue Growth Rate (2015-2025)
10.5 Monoclonal Antibodies Revenue Growth Rate (2015-2025)
10.6 Hormones Revenue Growth Rate (2015-2025)
10.7 Enzyme Revenue Growth Rate (2015-2025)
10.8 Coagulation Factors Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Recombinant Therapeutic Antibodies and Proteins Market Segment by Application
11.1 Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Application (2015-2020)
11.2 Recombinant Therapeutic Antibodies and Proteins Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Hematology Revenue Growth (2015-2020)
11.5 Immunology Revenue Growth (2015-2020)
11.6 Endocrinology Revenue Growth (2015-2020)
11.7 Infectious Disease Revenue Growth (2015-2020)
11.8 Cardiovascular Disease Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global Recombinant Therapeutic Antibodies and Proteins Market Size Forecast (2021-2025)
12.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size Forecast (2021-2025)
12.2 Global Recombinant Therapeutic Antibodies and Proteins Market Forecast by Regions (2021-2025)
12.3 North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
12.4 Europe Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
12.6 South America Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant Therapeutic Antibodies and Proteins by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Recombinant Therapeutic Antibodies and Proteins Major Business
Table 7. Abbott Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 10. Abbott Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novo Nordisk Corporate Information, Location and Competitors
Table 12. Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Major Business
Table 13. Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2018-2019)
Table 14. Novo Nordisk SWOT Analysis
Table 15. Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 16. Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eli Lilly Corporate Information, Location and Competitors
Table 18. Eli Lilly Recombinant Therapeutic Antibodies and Proteins Major Business
Table 19. Eli Lilly Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2017-2018)
Table 20. Eli Lilly SWOT Analysis
Table 21. Eli Lilly Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 22. Eli Lilly Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Amgen Corporate Information, Location and Competitors
Table 24. Amgen Recombinant Therapeutic Antibodies and Proteins Major Business
Table 25. Amgen Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2017-2018)
Table 26. Amgen SWOT Analysis
Table 27. Amgen Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 28. Amgen Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Recombinant Therapeutic Antibodies and Proteins Major Business
Table 31. Merck Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 34. Merck Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Biogen Corporate Information, Location and Competitors
Table 36. Biogen Recombinant Therapeutic Antibodies and Proteins Major Business
Table 37. Biogen Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2017-2018)
Table 38. Biogen SWOT Analysis
Table 39. Biogen Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 40. Biogen Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sanofi Corporate Information, Location and Competitors
Table 42. Sanofi Recombinant Therapeutic Antibodies and Proteins Major Business
Table 43. Sanofi Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2017-2018)
Table 44. Sanofi SWOT Analysis
Table 45. Sanofi Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 46. Sanofi Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Johnson and Johnson Corporate Information, Location and Competitors
Table 48. Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Major Business
Table 49. Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2017-2018)
Table 50. Johnson and Johnson SWOT Analysis
Table 51. Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 52. Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Recombinant Therapeutic Antibodies and Proteins Major Business
Table 55. Roche Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 58. Roche Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pfizer Corporate Information, Location and Competitors
Table 60. Pfizer Recombinant Therapeutic Antibodies and Proteins Major Business
Table 61. Pfizer Recombinant Therapeutic Antibodies and Proteins Total Revenue (USD Million) (2017-2018)
Table 62. Pfizer SWOT Analysis
Table 63. Pfizer Recombinant Therapeutic Antibodies and Proteins Product and Solutions
Table 64. Pfizer Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) by Players (2015-2020)
Table 66. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Players (2015-2020)
Table 67. Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions (2015-2020)
Table 69. North America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2015-2020)
Table 70. North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2015-2020)
Table 71. Europe Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Recombinant Therapeutic Antibodies and Proteins Revenue by Countries (2015-2020)
Table 74. South America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2015-2020)
Table 77. Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) by Type (2015-2020)
Table 78. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Type (2015-2020)
Table 79. Global Recombinant Therapeutic Antibodies and Proteins Revenue Forecast by Type (2021-2025)
Table 80. Global Recombinant Therapeutic Antibodies and Proteins Revenue by Application (2015-2020)
Table 81. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Application (2015-2020)
Table 82. Global Recombinant Therapeutic Antibodies and Proteins Revenue Forecast by Application (2021-2025)
Table 83. Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Recombinant Therapeutic Antibodies and Proteins Picture
Figure 2. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Type in 2019
Figure 3. Plasma Protein Picture
Figure 4. Fusion Proteins Picture
Figure 5. Monoclonal Antibodies Picture
Figure 6. Hormones Picture
Figure 7. Enzyme Picture
Figure 8. Coagulation Factors Picture
Figure 9. Others Picture
Figure 10. Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Application in 2019
Figure 11. Oncology Picture
Figure 12. Hematology Picture
Figure 13. Immunology Picture
Figure 14. Endocrinology Picture
Figure 15. Infectious Disease Picture
Figure 16. Cardiovascular Disease Picture
Figure 17. Others Picture
Figure 18. Global Recombinant Therapeutic Antibodies and Proteins Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. North America Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Europe Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. South America Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Players in 2019
Figure 26. Global Top 5 Players Recombinant Therapeutic Antibodies and Proteins Revenue Market Share in 2019
Figure 27. Global Top 10 Players Recombinant Therapeutic Antibodies and Proteins Revenue Market Share in 2019
Figure 28. Key Players Market Share Trend
Figure 29. Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 30. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions (2015-2020)
Figure 31. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Regions in 2018
Figure 32. North America Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 33. Europe Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 34. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 35. South America Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 36. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 37. North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2015-2020)
Figure 38. North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2019
Figure 39. USA Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 40. Canada Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 41. Mexico Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 42. Europe Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2015-2020)
Figure 43. Europe Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2019
Figure 44. Germany Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 45. UK Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 46. France Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 47. Russia Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 48. Italy Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 49. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2015-2020)
Figure 50. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2019
Figure 51. China Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 52. Japan Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 53. Korea Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 54. India Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 55. Southeast Asia Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 56. South America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2015-2020)
Figure 57. South America Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2019
Figure 58. Brazil Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 59. Argentina Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 60. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries (2015-2020)
Figure 61. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Countries in 2019
Figure 62. Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 63. UAE Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 64. Egypt Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 65. South Africa Recombinant Therapeutic Antibodies and Proteins Revenue and Growth Rate (2015-2020)
Figure 66. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Type (2015-2020)
Figure 67. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Type in 2019
Figure 68. Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Type (2021-2025)
Figure 69. Global Plasma Protein Revenue Growth Rate (2015-2020)
Figure 70. Global Fusion Proteins Revenue Growth Rate (2015-2020)
Figure 71. Global Monoclonal Antibodies Revenue Growth Rate (2015-2020)
Figure 72. Global Hormones Revenue Growth Rate (2015-2020)
Figure 73. Global Enzyme Revenue Growth Rate (2015-2020)
Figure 74. Global Coagulation Factors Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Application (2015-2020)
Figure 77. Global Recombinant Therapeutic Antibodies and Proteins Revenue Share by Application in 2019
Figure 78. Global Recombinant Therapeutic Antibodies and Proteins Market Share Forecast by Application (2021-2025)
Figure 79. Global Oncology Revenue Growth Rate (2015-2020)
Figure 80. Global Hematology Revenue Growth Rate (2015-2020)
Figure 81. Global Immunology Revenue Growth Rate (2015-2020)
Figure 82. Global Endocrinology Revenue Growth Rate (2015-2020)
Figure 83. Global Infectious Disease Revenue Growth Rate (2015-2020)
Figure 84. Global Cardiovascular Disease Revenue Growth Rate (2015-2020)
Figure 85. Global Others Revenue Growth Rate (2015-2020)
Figure 86. Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 87. Global Recombinant Therapeutic Antibodies and Proteins Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 88. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share Forecast by Regions (2021-2025)
Figure 89. North America Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
Figure 90. Europe Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
Figure 91. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
Figure 92. South America Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
Figure 93. Middle East and Africa Recombinant Therapeutic Antibodies and Proteins Revenue Market Forecast (2021-2025)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
組換えヒトタンパク質の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Human Proteins market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant Human …- CD38モノクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The CD38 Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 新型コロナウイルス感染症組換えタンパク質ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 Recombinant Protein Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
- 代替タンパク質の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Alternative Proteins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 遺伝子工学の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Genetic Engineering market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4526 million by 2025, from USD 3141.9 million in 2019. The Genetic Engineerin…